1. Home
  2. SEER vs CSBR Comparison

SEER vs CSBR Comparison

Compare SEER & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.78

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$6.00

Market Cap

83.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
CSBR
Founded
2017
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
83.5M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
SEER
CSBR
Price
$1.78
$6.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
364.2K
6.1K
Earning Date
05-13-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
9.40
161.11
EPS
N/A
N/A
Revenue
$16,578,000.00
$2,900,000.00
Revenue This Year
$2.14
$4.84
Revenue Next Year
$25.90
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.65
$5.50
52 Week High
$2.41
$9.63

Technical Indicators

Market Signals
Indicator
SEER
CSBR
Relative Strength Index (RSI) 45.19 44.80
Support Level $1.76 $5.60
Resistance Level $1.84 $6.31
Average True Range (ATR) 0.07 0.25
MACD -0.01 -0.02
Stochastic Oscillator 32.26 14.27

Price Performance

Historical Comparison
SEER
CSBR

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: